Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA

Cited by (1,007)

Items 501–600 of 1,007

  1. Human Pluripotent Stem Cell-Derived Cardiomyocytes as Research and Therapeutic Tools
    Ivana Aćimović, Aleksandra Vilotić, Martin Pešl, Alain Lacampagne, Petr Dvořák, Vladimír Rotrekl, Albano C. Méli · 2014 · BioMed Research International
  2. miR-128 represses L1 retrotransposition by binding directly to L1 RNA
    Matthias Hamdorf, Adam Idica, Dimitrios G. Zisoulis, Lindsay Gamelin, Charles Martin, Katie J. Sanders, Irene Munk Pedersen · 2015 · Nature Structural & Molecular Biology
  3. Synthetic Chemically Modified mRNA-Based Delivery of Cytoprotective Factor Promotes Early Cardiomyocyte Survival Post-Acute Myocardial Infarction
    Chien‐Ling Huang, Anne‐Laure Leblond, Elizebeth C. Turner, Arun H. S. Kumar, Kenneth Martin, Derek Whelan, Donnchadh M. O’Sullivan, Noel M. Caplice · 2015 · Molecular Pharmaceutics
  4. Skeletal Muscle Cell Induction from Pluripotent Stem Cells
    Yusaku Kodaka, Gemachu Rabu, Atsushi Asakura · 2017 · Stem Cells International
  5. Improving Immunotherapy Through Glycodesign
    Matthew J. Buettner, Sagar R Shah, Christopher T. Saeui, Ryan Ariss, Kevin J. Yarema · 2018 · Frontiers in Immunology
  6. Rat embryonic fibroblasts improve reprogramming of human keratinocytes into induced pluripotent stem cells
    Linta, Leonhard, Stockmann, Marianne, Kleinhans, Karin N., Böckers, Anja, Storch, Alexander, Zaehres, Holm, Lin, Qiong, Barbi, Gotthold, Böckers, Tobias M., Kleger, Alexander et al. · 2012 · Stem Cells and Development
  7. Chemical Strategies for Stem Cell Biology and Regenerative Medicine
    Saiyong Zhu, Wanguo Wei, Sheng Ding · 2011 · Annual Review of Biomedical Engineering
  8. Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility
    Adriana Blazeski, Renjun Zhu, David W. Hunter, Seth H. Weinberg, Elias T. Zambidis, Leslie Tung · 2012 · Progress in Biophysics and Molecular Biology
  9. Inducing iPSCs to Escape the Dish
    Bonnie L. Barrilleaux, Paul S. Knoepfler · 2011 · Cell stem cell
  10. RNA-Based Tools for Nuclear Reprogramming and Lineage-Conversion: Towards Clinical Applications
    J. A. Bernal · 2013 · Journal of Cardiovascular Translational Research
  11. Stem cell markers in glioma progression and recurrence
    Kirsten Hattermann, Charlotte Flüh, Dorothee Engel, Hubertus Maximilian Mehdorn, Michael Synowitz, Rolf Mentlein, Janka Held‐Feindt · 2016 · International Journal of Oncology
  12. Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential
    Alain van Mil, Geerthe Margriet Balk, Klaus Neef, Jan Willem Buikema, Folkert Wouter Asselbergs, Sean M. Wu, Pieter A. Doevendans, Joost P. G. Sluijter · 2018 · Cardiovascular Research
  13. Cell-mediated delivery of VEGF modified mRNA enhances blood vessel regeneration and ameliorates murine critical limb ischemia
    Ziyou Yu, Nevin Witman, Wenbo Wang, Dong Li, Bingqian Yan, Mingwu Deng, Xiangsheng Wang, Huijing Wang, Guangdong Zhou, Wei Xin Liu et al. · 2019 · Journal of Controlled Release
  14. Generating Human Neurons In Vitro and Using Them to Understand Neuropsychiatric Disease
    Sergiu P. Pașca, Georgia Panagiotakos, Ricardo E. Dolmetsch · 2014 · Annual Review of Neuroscience
  15. Exploring the epitranscriptome by native RNA sequencing
    Oguzhan Begik, John S. Mattick, Eva Maria Novoa · 2022 · RNA
  16. Enhanced adipose-derived stem cells with IGF-1-modified mRNA promote wound healing following corneal injury
    Fei Yu, Danni Gong, Dan Yan, Huijing Wang, Nevin Witman, Lu Yang, Wei En Fu, Yao Fu · 2023 · Molecular Therapy
  17. Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells
    Xiaohong Xu, Zhong Zhong · 2013 · Acta Pharmacologica Sinica
  18. Generating iPSCs: Translating Cell Reprogramming Science into Scalable and Robust Biomanufacturing Strategies
    Marli Silva, Laurence M. Daheron, Hannah Hurley, Kim Bure, Richard Barker, Andrew Jonathan Carr, David Williams, Hae‐Won Kim, Anna French, Peter J. Coffey et al. · 2015 · Cell stem cell
  19. Induced Pluripotent Stem Cells: Advances in the Quest for Genetic Stability during Reprogramming Process
    Valentina Turinetto, Luca Orlando, Claudia Giachino · 2017 · International Journal of Molecular Sciences
  20. Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
    Yun Bai, Shifeng Kan, Shixin Zhou, Yuting Wang, Jun Xu, John P. Cooke, Jinhua Wen, Hongkui Deng · 2015 · Cell Discovery
  21. Synthetic Chemically Modified mRNA (modRNA): Toward a New Technology Platform for Cardiovascular Biology and Medicine
    Kenneth R. Chien, Lior Zangi, Kathy O. Lui · 2014 · Cold Spring Harbor Perspectives in Medicine
  22. Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
    Deepta Bhattacharya · 2022 · Immunity
  23. Generation of Induced Pluripotent Stem Cells from Human Renal Proximal Tubular Cells with Only Two Transcription Factors, Oct4 and Sox2
    Núria Montserrat, María José Ramírez-Bajo, Yun Fei Xia, Ignacio Sancho-Martinez, Daniel Moya-Rull, Laia Miquel‐Serra, Shenglian Yang, Emmanuel Nivet, Carme Cortina, Federico Gonzãlez et al. · 2012 · Journal of Biological Chemistry
  24. Footprint‐Free Human Induced Pluripotent Stem Cells From Articular Cartilage With Redifferentiation Capacity: A First Step Toward a Clinical‐Grade Cell Source
    Cecilia Boreström, S. Simonsson, L. Enochson, N. Bigdeli, C. Brantsing, Catharina Ellerström, J. Hyllner, A. Lindahl · 2014 · Stem Cells Translational Medicine
  25. Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming
    Chao‐Shun Yang, Kung‐Yen Chang, Tariq M. Rana · 2014 · Cell Reports
  26. Novel codon-optimized mini-intronic plasmid for efficient, inexpensive and xeno-free induction of pluripotency
    Sebastian Diecke, Jiamiao Lu, Jaecheol Lee, Vittavat Termglinchan, Nigel G. Kooreman, Paul W. Burridge, Antje Ebert, Jared M. Churko, Arun Sharma, Mark A. Kay et al. · 2015 · Scientific Reports
  27. Human pluripotent stem cells for disease modelling and drug screening
    Yves Maury, Morgane Gauthier, Marc Peschanski, Cécile Martinat · 2011 · BioEssays
  28. Attenuation of Hind-Limb Ischemia in Mice with Endothelial-Like Cells Derived from Different Sources of Human Stem Cells
    Wing‐Hon Lai, Jenny Chung-Yee Ho, Yau-Chi Chan, Joyce H. L. Ng, Ka‐Wing Au, Lai-Yung Wong, Chung‐Wah Siu, Hung‐Fat Tse · 2013 · PLoS ONE
  29. A Cyclic AMP Analog, 8-Br-cAMP, Enhances the Induction of Pluripotency in Human Fibroblast Cells
    Ying Wang, James Adjaye · 2010 · Stem Cell Reviews and Reports
  30. Induced Pluripotent Stem Cells from Human Hair Follicle Mesenchymal Stem Cells
    Yimei Wang, Jinyu Liu, Xiaohua Tan, Gaofeng Li, Yunhe Gao, Xuejuan Liu, Lihong Zhang, Yulin Li · 2012 · Stem Cell Reviews and Reports
  31. Non-Viral Methods For Generating Integration-Free, Induced Pluripotent Stem Cells
    Xiaoyue Deng, Hu Wang, Tao Wang, Xian-Tao Fang, Lili Zou, Zhiying Li, Chang-Bai Liu · 2015 · Current Stem Cell Research & Therapy
  32. Fate of induced pluripotent stem cells following transplantation to murine seminiferous tubules
    Jens Durruthy-Durruthy, Cyril Y. Ramathal, Meena Sukhwani, Fang Fang, Jun Cui, Kyle E. Orwig, Renee A. Reijo Pera · 2014 · Human Molecular Genetics
  33. Embryonic Stem Cells or Induced Pluripotent Stem Cells? A DNA Integrity Perspective
    Qiang Baï, Romain Desprat, Bernard Klein, Jean-Marc Lemaı̂tre, John De Vos · 2013 · Current Gene Therapy
  34. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions
    Juan Wang, Jie Hao, Donghui Bai, Qi Gu, Weifang Han, Lei Wang, Yuanqing Tan, Xia Li, Ke Xue, Pencheng Han et al. · 2015 · Stem Cell Research & Therapy
  35. An Improved, Chemically Modified RNA Encoding BMP-2 Enhances Osteogenesis In Vitro and In Vivo
    Wen Zhang, Rodolfo E. De la Vega, Michael J. Coenen, Sebastian Müller, Carlos Julio Peniche Silva, Manish Kumar Aneja, Christian Plank, Martijn van Griensven, Christopher H. Evans, Elizabeth Rosado Balmayor · 2018 · Tissue Engineering Part A
  36. Dedifferentiation, transdifferentiation and cell fusion: in vivo reprogramming strategies for regenerative medicine
    Martina Pesaresi, Rubén Sebastián-Pérez, Maria Pia Cosma · 2018 · FEBS Journal
  37. Reducible Branched Ester-Amine Quadpolymers (rBEAQs) Codelivering Plasmid DNA and RNA Oligonucleotides Enable CRISPR/Cas9 Genome Editing
    Yuan Rui, David R. Wilson, Katie Sanders, Jordan J. Green · 2019 · ACS Applied Materials & Interfaces
  38. Advanced models of human skeletal muscle differentiation, development and disease: Three-dimensional cultures, organoids and beyond
    Salma Jalal, Sumitava Dastidar, Francesco Saverio Tedesco · 2021 · Current Opinion in Cell Biology
  39. Neural Stem Cells Differentiated From iPS Cells Spontaneously Regain Pluripotency
    Hyun Woo Choi, Jong Soo Kim, Sol Choi, Yean Ju Hong, Min Jung Kim, Han Geuk Seo, Jeong Tae · 2014 · Stem Cells
  40. Exploring refined conditions for reprogramming cells by recombinant Oct4 protein
    Marc Christian Thier, Bernhard Mnst, Frank Edenhofer · 2010 · The International Journal of Developmental Biology
  41. Strategies for Whole Lung Tissue Engineering
    Elizabeth A. Calle, Mahboobe Ghaedi, Sumati Sundaram, Amogh Sivarapatna, Michelle K. Tseng, Laura E. Niklason · 2014 · IEEE Transactions on Biomedical Engineering
  42. Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis.
    Takuji Suzuki, C. Mayhew, A. Sallese, C. Chalk, B. Carey, P. Malik, R. Wood, B. Trapnell · 2013 · American Journal of Respiratory and Critical Care Medicine
  43. Induced Pluripotent Stem Cells: Fundamentals and Applications of the Reprogramming Process and its Ramifications on Regenerative Medicine
    Bhavita Walia, Neeraj Kumar Satija, Rajendra Prashad Tripathi, Gurudutta U. Gangenahalli · 2011 · Stem Cell Reviews and Reports
  44. The Pharmacology of Regenerative Medicine
    George Joseph Christ, Justin M. Saul, Mark E. Furth, Karl‐Erik Andersson · 2013 · Pharmacological Reviews
  45. Genome-Scale CRISPRa Screen Identifies Novel Factors for Cellular Reprogramming
    Jian Ping Yang, Sandeep S. Rajan, Mathias Friedrich, Guocheng Lan, Xiangang Zou, Hannes Ponstingl, Dimitrios A. Garyfallos, Pentao Liu, Allan Bradley, Emmanouil Metzakopian · 2019 · Stem Cell Reports
  46. Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
    Giacomelli, E., Mummery, C. L., Bellin, M. · 2017 · Cellular and Molecular Life Sciences
  47. Novel Molecular Therapies for Heritable Skin Disorders
    Jouni Uitto, Angela M. Christiano, W.H. Irwin McLean, John Alexander McGrath · 2011 · Journal of Investigative Dermatology
  48. Human artificial chromosome-based gene delivery vectors for biomedicine and biotechnology
    Natalay Kouprina, Alexey N. Tomilin, Hiroshi Masumoto, William C. Earnshaw, Vladimir Larionov · 2014 · Expert Opinion on Drug Delivery
  49. Developing nociceptor-selective treatments for acute and chronic pain
    Selwyn S. Jayakar, Jaehoon Shim, Sooyeon Jo, Bruce P. Bean, Ilyas Singeç, Clifford J. Woolf · 2021 · Science Translational Medicine
  50. The Current Status of iPS Cells in Cardiac Research and Their Potential for Tissue Engineering and Regenerative Medicine
    Ana M. Martins, Gordana Vunjak‐Novakovic, Rui Luís Reis · 2014 · Stem Cell Reviews and Reports
  51. Bladder tissue engineering: A literature review
    Ornella Lam Van Ba, Shachar Moshe Aharony, Oleg Loutochin, Jacques Corcos · 2014 · Advanced Drug Delivery Reviews
  52. Using iPS Cells toward the Understanding of Parkinson’s Disease
    Roger Torrent, Francesca Rigotti, Patrizia Dell’Era, Maurizio Memo, Ángel Raya, Antonella Consiglio · 2015 · Journal of Clinical Medicine
  53. Engineering Biomaterials with Micro/Nanotechnologies for Cell Reprogramming
    Jun Fang, Yuan‐Yu Hsueh, Jennifer Soto, Wujin Sun, Jinqiang Wang, Zhen Gu, Ali Khademhosseini, Song Li · 2020 · ACS Nano
  54. Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders
    Qiang, Liang, Fujita, Ryousuke, Abeliovich, Asa · 2013 · Neuron
  55. Loss of the fragile X syndrome protein FMRP results in misregulation of nonsense-mediated mRNA decay
    Tatsuaki Kurosaki, Naoto Imamachi, Christoph Pröschel, Shuhei Mitsutomi, Rina Nagao, Nobuyoshi Akimitsu, Lynne E. Maquat · 2021 · Nature Cell Biology
  56. Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer’s disease
    Vanesa R. Hyde, Chaoming Zhou, J R Muñóz y Fernández, Krishnashis Chatterjee, Pururav Ramakrishna, Amanda Lin, Gregory W. Fisher, Orhan T. Celiker, Jill Caldwell, Omer Bender et al. · 2025 · Cell Reports
  57. Induced Pluripotent Stem Cell Consensus Genes: Implication for the Risk of Tumorigenesis and Cancers in Induced Pluripotent Stem Cell Therapy
    Gaochuan Zhang, Bingxue Shang, Ping Yang, Zhifei Cao, Yanyan Pan, Quansheng Zhou · 2011 · Stem Cells and Development
  58. A Practical and Efficient Cellular Substrate for the Generation of Induced Pluripotent Stem Cells from Adults: Blood-Derived Endothelial Progenitor Cells
    Imbisaat Geti, Mark L. Ormiston, Foad J. Rouhani, Mark R. Toshner, Mehregan Movassagh, Jennifer Nichols, William M. Mansfield, Mark R. Southwood, Allan Bradley, Amer Ahmed Rana et al. · 2012 · Stem Cells Translational Medicine
  59. Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine
    Ana Revilla, Clara González, Amaia Iriondo, Bárbara Fernández, Cristina Prieto, Carlos Marín, Isabel Liste · 2015 · Journal of Tissue Engineering and Regenerative Medicine
  60. Dysregulations of Functional RNA Modifications in Cancer, Cancer Stemness and Cancer Therapeutics
    Mohammad B. Uddin, Zhishan Wang, Chengfeng Yang · 2020 · Theranostics
  61. Human‐Induced Pluripotent Stem Cell Culture Methods Under cGMP Conditions
    Teresa Rivera, Yuanyuan Zhao, Yuhui Ni, Jiwu Wang · 2020 · Current Protocols in Stem Cell Biology
  62. Extracellular matrix mechanics regulate transfection and SOX9-directed differentiation of mesenchymal stem cells
    Adriana M. Ledo, Kyle H. Vining, Marı́a José Alonso, Marcos García-Fuentes, David J. Mooney · 2020 · Acta Biomaterialia
  63. Cytidine-containing tails robustly enhance and prolong protein production of synthetic mRNA in cell and in vivo
    Cheuk Yin Li, Zhenghua Liang, Yaxin Hu, Hongxia Zhang, Kharis Daniel Setiasabda, Jiawei Li, Shaohua Ma, Xiaojun Xia, Yi Kuang · 2022 · Molecular Therapy — Nucleic Acids
  64. Modeling Timothy Syndrome with iPS Cells
    Masayuki Yazawa, Ricardo E. Dolmetsch · 2013 · Journal of Cardiovascular Translational Research
  65. Assessing the Risks of Genotoxicity in the Therapeutic Development of Induced Pluripotent Stem Cells
    So Gun Hong, Cynthia E. Dunbar, Thomas Winkler · 2012 · Molecular Therapy
  66. Human induced pluripotent stem cells—from mechanisms to clinical applications
    Katharina Drews, Justyna Józefczuk, Alessandro Prigione, James Adjaye · 2012 · Journal of Molecular Medicine
  67. Vectorology and Factor Delivery in Induced Pluripotent Stem Cell Reprogramming
    Kejin Hu · 2014 · Stem Cells and Development
  68. Generation of CD34 + Cells from CCR5-Disrupted Human Embryonic and Induced Pluripotent Stem Cells
    Yongchao Yao, Bayaer Nashun, Tiancheng Zhou, Qin Li, Limei Qin, Siting Zhao, Jianyong Xu, Miguel Angel Esteban, Xiaoping Chen · 2011 · Human Gene Therapy
  69. Making a Hematopoietic Stem Cell
    Michael G. Daniel, Carlos‐Filipe Pereira, Ihor R. Lemischka, Kateri Ann Moore · 2015 · Trends in Cell Biology
  70. 2′Fluoro Modification Differentially Modulates the Ability of RNAs to Activate Pattern Recognition Receptors
    Young-Ju Lee, Johannes H. Urban, Li Xu, Bruce A. Sullenger, Jaewoo Lee · 2016 · Nucleic Acid Therapeutics
  71. A Combinatorial Library of Unsaturated Lipidoids for Efficient Intracellular Gene Delivery
    Ming Wang, Shuo Sun, Kyle A. Alberti, Qiaobing Xu · 2012 · ACS Synthetic Biology
  72. Design, Assembly, Production, and Transfection of Synthetic Modified mRNA
    Oh, Sanders, Kessler, John A. · 2018 · Methods
  73. Genomic Instability of iPSCs and Challenges in Their Clinical Applications
    Masahito Yoshihara, Akiko Oguchi, Yasuhiro Murakawa · 2019 · Advances in experimental medicine and biology
  74. RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA Vaccines
    Rauch, Susanne, Lutz, Johannes, Kowalczyk, Aleksandra, Schlake, Thomas, Heidenreich, Regina · 2017 · Methods in Molecular Biology
  75. The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines
    Wei, Jiao, Hui, Ai-Min · 2022 · Cancer Treatment Reviews
  76. Development and applications of mRNA treatment based on lipid nanoparticles
    Zhe Wang, Wanting Ma, Xingxing Fu, Yanfei Qi, Yinan Zhao, Shubiao Zhang · 2023 · Biotechnology Advances
  77. Pervasive transcriptome interactions of protein-targeted drugs
    Linglan Fang, Willem A. Velema, Yujeong Lee, Lu Xiao, Michael G. Mohsen, Anna M. Kietrys, Eric T. Kool · 2023 · Nature Chemistry
  78. Generation of Human-Induced Pluripotent Stem Cells to Model Spinocerebellar Ataxia Type 2 In vitro
    Guangbin Xia, Katherine E. Santostefano, Takashi Hamazaki, Jilin Liu, S. H. Subramony, Naohiro Terada, Tetsuo Ashizawa · 2012 · Journal of Molecular Neuroscience
  79. Gene Therapy and Biological Pacing
    Michael R. Rosen · 2014 · New England Journal of Medicine
  80. Induced Pluripotent Stem Cell Reprogramming by Integration-Free Sendai Virus Vectors from Peripheral Blood of Patients with Craniometaphyseal Dysplasia
    I. Chen, K. Fukuda, N. Fusaki, A. Iida, M. Hasegawa, A. Lichtler, E. Reichenberger · 2013 · Cellular Reprogramming
  81. Modeling Heterogeneous Patients With a Clinical Diagnosis of Schizophrenia With Induced Pluripotent Stem Cells
    Kristen Brennand, Melissa A. Landek‐Salgado, Akira Sawa · 2013 · Biological Psychiatry
  82. Amniocytes can serve a dual function as a source of iPS cells and feeder layers
    R. Anchan, P. Quaas, B. Gerami-Naini, Hrishikesh Bartake, A. Griffin, Yi-Lan Zhou, Daniel S. Day, J. Eaton, Liji L. George, C. Naber et al. · 2010 · Human Molecular Genetics
  83. β‐Cell regeneration through the transdifferentiation of pancreatic cells: Pancreatic progenitor cells in the pancreas
    Hyo‐Sup Kim, Moon‐Kyu Lee · 2016 · Journal of Diabetes Investigation
  84. Impaired mitochondrial–endoplasmic reticulum interaction and mitophagy in Miro1-mutant neurons in Parkinson’s disease
    Clara Berenguer-Escuder, Dajana Großmann, Paul M. A. Antony, Giuseppe Arena, Kobi Wasner, François Massart, Javier Jarazo, Jonas Walter, Jens Christian Schwamborn, Anne Grünewald et al. · 2020 · Human Molecular Genetics
  85. Recent developments in transposon-mediated gene therapy
    Mario Di Matteo, Eyayu Belay, Marinee Chuah, Thierry VandenDriessche · 2012 · Expert Opinion on Biological Therapy
  86. Induced Tissue-Specific Stem Cells and Epigenetic Memory in Induced Pluripotent Stem Cells
    Hirofumi Noguchi, Chika Miyagi‐Shiohira, Yoshiki Nakashima · 2018 · International Journal of Molecular Sciences
  87. Induced pluripotent stem cell-derived vascular smooth muscle cells: methods and application
    Biraja C. Dash, Zhengxin Jiang, Carol Y. Suh, Yibing Qyang · 2015 · Biochemical Journal
  88. Nonxenogeneic Growth and Retinal Differentiation of Human Induced Pluripotent Stem Cells
    Akshayalakshmi Sridhar, Melissa Steward, Jason S. Meyer · 2013 · Stem Cells Translational Medicine
  89. The science and ethics of induced pluripotency: what will become of embryonic stem cells?
    David G. Zacharias, Timothy J. Nelson, P. S. Mueller, C. Hook · 2011 · Mayo Clinic proceedings
  90. Induction of human pluripotent stem cells into kidney tissues by synthetic mRNAs encoding transcription factors
    Ken Hiratsuka, Toshiaki Monkawa, Tomohiko Akiyama, Yuhki Nakatake, Mayumi Oda, Sravan Kumar Goparaju, Hiromi Kimura, Nana Chikazawa-Nohtomi, Saeko Sato, Kei‐ichiro Ishiguro et al. · 2019 · Scientific Reports
  91. A ‘poly-transfection’ method for rapid, one-pot characterization and optimization of genetic systems
    Jeremy J Gam, Breanna DiAndreth, Ross D. Jones, Jin H. Huh, Ron Weiss · 2019 · Nucleic Acids Research
  92. RNA therapeutics: Identification of novel targets leading to drug discovery
    Muhammad Imran Qadir, Sherien Bukhat, Sumaira Rasul, Hamid Manzoor, Majid Manzoor · 2019 · Journal of Cellular Biochemistry
  93. Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine
    Yu Qiao, Oluwafemi Solomon Agboola, Xinglin Hu, Yanshuang Wu, Lei Lei · 2020 · Stem Cell Reviews and Reports
  94. Optimization of Lipid Nanoformulations for Effective mRNA Delivery
    Huiling Chen, Xuan Ren, Xu Shi, Dekui Zhang, Tiyun Han · 2022 · International Journal of Nanomedicine
  95. Stem Cell-Based Therapy for Spinal Cord Injury
    Vladislav Volarević, Slaven Erceg, Shomi S. Bhattacharya, Petra Stojković, Philip J. Horner, Miodrag Stojković · 2013 · Cell Transplantation
  96. Regenerating functional heart tissue for myocardial repair
    Andre Alcon, Esra Çağavi, Yibing Qyang · 2012 · Cellular and Molecular Life Sciences
  97. How microRNAs facilitate reprogramming to pluripotency
    Frederick Anokye-Danso, Melinda E. Snitow, E. Morrisey · 2012 · Journal of Cell Science
  98. Concise Review: Human Pluripotent Stem Cells in the Treatment of Spinal Cord Injury
    Dunja Lukovic, Victoria Moreno‐Manzano, Miodrag Stojković, Shomi S. Bhattacharya, Slaven Erceg · 2012 · Stem Cells
  99. Cells derived from murine induced pluripotent stem cells (iPSC) by treatment with members of TGF-beta family give rise to osteoblasts differentiation and form bone in vivo
    Feng Li, Christopher Niyibizi · 2012 · BMC Cell Biology
  100. Pharmacoelectrophysiology of Viral-Free Induced Pluripotent Stem Cell–Derived Human Cardiomyocytes
    Ashish K. Mehta, Ying Ying Chung, Glen Lester Sequiera, Philip Wong, Reginald Liew, WINSTON S. N. SHIM · 2012 · Toxicological Sciences